Cognitive deficits in patients with brain tumor

( views:24, downloads:0 )
Author:
SHEN Chao(Department of Neurosurgery, Huashan Hospital, Fudan University,Shanghai 200040, China)
BAO Wei-min(Institute of Neurology, Fudan University, Shanghai 200040, China)
YANG Bo-jie(Department of Neurosurgery, Huashan Hospital, Fudan University,Shanghai 200040, China)
XIE Rong(Department of Neurosurgery, Huashan Hospital, Fudan University,Shanghai 200040, China)
CAO Xiao-yun(Institute of Neurology, Fudan University, Shanghai 200040, China)
LUAN Shi-hai(Department of Neurosurgery, Huashan Hospital, Fudan University,Shanghai 200040, China)
MAO Ying(Department of Neurosurgery, Huashan Hospital, Fudan University,Shanghai 200040, China)
Journal Title:
Chinese Medical Journal
Issue:
Volume 125, Issue 14, 2012
DOI:
10.3760/cma.j.issn.0366-6999.2012.14.037
Key Word:
cognitive deficits;glioma;meningeoma;surgery;radiotherapy;chemotherapy

Abstract: Objective To discuss the present status and progress of clinical research on the cognitive effects caused by different types of brain tumors and common treatments.Data sources The data used in this review were mainly from PubMed articles published in English from 1990 to Febuary 2012.Research terms were "cognitive deficits" or "cognitive dysfunction".Study selection Articals including any information about brain tumor related cognitive deficits were selected.Results It is widely accepted that brain tumors and related treatments can impair cognitive function across manydomains,and can impact on patients' quality of life.Tumor localization,lateralization,surgery,drugs,radiotherapy and chemotherapy are all thought to be important factors in this process.However,some conflicting findings regarding brain tumor-related cognitive deficits have been reported.It can be difficult to determine the mechanism of these treatments,such as chemotherapy,antibiotics,antiepileptics,and steroids.Future research is needed to clarify these potential treatment effects.Conclusions Cognitive function is important for patients with brain tumor.Much more focus has been paid on this field.It should be regarded as an important prognostic index for the patients with brain tumor,and neuropsychological tests should be used in regular examinations.

  • 1.Minski L.The mental symptoms associated with 58 cases of cerebral tumour.J Neurol Psychopatho 1938; 13:330-343.
  • 2.Tucha O,Smely C,Preier M,Lange KW.Cognitive deficits before treatment among patients with brain tumors.Neurosurgery 2000; 47:324-334.
  • 3.Olson JD,Riedel E,DeAngelis LM.Long-term outcome of low-grade oligodendroglioma and mixed glioma.Neurology 2000; 54:1442-1448.
  • 4.Weitzner MA,Meyers CA.Cognitive functioning and quality of life in malignant glioma patients:a review of the literature.Psychooncology 1997; 6:169-177.
  • 5.Klein M,Duffau H,De Witt Hamer PC.Cognition and resective surgery for diffuse infiltrative glioma:an overview.J Neurooncol 2012; 108:309-318.
  • 6.Meyers CA,Hess KR.Muitifaceted end points in brain tumor clinical trials:cognitive deterioration precedes MRI progression.Neuro Oncol 2003; 5:89-95.
  • 7.Meyers CA,Scheibel RS.Early detection and diagnosis of neurobehavioral disorders associated with cancer and its treatment.Oncology (Williston Park) 1990; 4:115-122;discussion 122,126-127,130.
  • 8.Gehring K,Sitskoom MM,Aaronson NK,Taphoorn MJB.Interventions for cognitive deficits in adults with brain tumours.Lancet Neurol 2008; 7:548-560.
  • 9.Meyers CA,Hess KR,Yung WK,Levin VA.Cognitive function as a predictor of survival in patients with recurrent malignant glioma.J Clin Oncol 2000; 18:646-650.
  • 10.Klein M,Postma TJ,Taphoorn MJ,Aaronson NK,Vandertop WP,Muller M,et al.The prognostic value of cognitive functioning in the survival of patients with high-grade glioma.Neurology 2003; 61:1796-1798.
  • 11.Scoccianti S,Detti B,Cipressi S,Iannalfi A,Franzese C,Biti G.Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.J Neurooncol 2012; 108:291-308.
  • 12.Reijneveld JC,Sitskoorn MM,Klein M,Nuyen J,Taphoorn MJ.Cognitive status and quality of life in patients with suspected versus proven low-grade gliomas.Neurology 2001;56:618-623.
  • 13.Klein M,Heimans JJ,Aaronson NK,van der Ploeg HM,Grit J,Muller M,et al.Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas:a comparative study.Lancet 2002; 360:1361-1368.
  • 14.Busch E.Psychical symptoms in neurosurgical disease.Acta Psychiatrica Et Neurologica 1940; 15:257-290.
  • 15.Lishman WA.Organic psychiatry:The psychological consequences of cerebral disorder.Boston:Blackwell Scientific Publishers; 1987.
  • 16.Scheibel RS,Meyers CA,Levin VA.Cognitive dysfunction following surgery for intracerebral glioma:influence of histopathology,lesion location,and treatment.J Neurooncol 1996; 30:61-69.
  • 17.Ek L,Smits A,Pahlson A,Almkvist O.Analysis of cognitive dysfunction in patients with low-grade glioma.J Clin Psychol Med S 2005; 12:165-173.
  • 18.Sweet JJ,Nies KJ,Lorber R,Vick NA.Relative absence of neuropsychological deficit in patients with low-grade astrocytomas.J Clin Psychol Med S 1994; 1:83-104.
  • 19.Baird A,Dewar BK,Critchley H,Gilbert SJ,Dolan RJ,Cipolotti L.Cognitive functioning after medial frontal lobe damage including the anterior cingulate cortex:a preliminary investigation.Brain Cogn 2006; 60:166-175.
  • 20.Giglio P,Benedict R,Duffner PK,Bakshi R,Cohen ME,Graham R.Cognitive deficits in children treated for tumors of the pineal region.Ann Neurol 2000; 48:541.
  • 21.Allegri RF,Drake M,Thomson A.Neuropsychological findings in patients with middle temporal lobe epilepsy.Rev Neurol 1999;29:1160-1163.
  • 22.Schmahmann JD.The role of the cerebellum in affect and psychosis.J Neurolinguist 2000; 13:189-214.
  • 23.Goto H,Nishizaki T,Kajiwara K,Ohmoto Y,Akimura T,Kato S,et al.Improvement in cognitive function after radical excision of an anterior skull base meningioma-a report of 2cases.J Clin Neurosci 2003; 10:375-378.
  • 24.Warrington EK,James M,Maciejewski C.The WAIS as a lateralizing and localizing diagnostic instrument:a study of 656 patients with unilateral cerebral lesions.Neuropsychologia 1986; 24:223-239.
  • 25.Luria AR.The neuropsychology of memory.New York:John Wilely & Sons; 1976.
  • 26.Bryden M.Functional asymmetry in the intact brain.New york:Academic Press; 1982.
  • 27.Glanzer M.Cerebral mechanisms of information storage:the problem of memory.In:Gazzaniga MS,ed.Handbook of Behavioral Neurobiology,2th ed.New york:Plenum Press;1982:465-493.
  • 28.Goldstein B,Armstrong CL,Modestino E,Ledakis G,John C,Hunter JV.The impact of left and right intracranial tumors on picture and word recognition memory.Brain Cogn 2004; 54:1-6.
  • 29.Shen C,Xie R,Bao WM,Guo QH,Yu G,Cao XY,et al.Preoperative and postoperative assessment of memory function for intracranial tumor patients.Natl Med J China (Chin) 2010; 90:301-304.
  • 30.Sasanuma S,Itoh M,Mori K,Kobayashi Y.Tachistoscopic recognition of kana and kanji words.Neuropsychologia 1977;15:547-553.
  • 31.Tucha O,Smely C,Preier M,Becker G,Paul GM,Lange KW.Preoperative and postoperative cognitive functioning in patients with frontal meningiomas.J Neurosurg 2003; 98:21-31.
  • 32.Tucha O,Smely C,Lange KW.Effects of surgery on cognitive functioning of elderly patients with intracranial meningioma.Br J Neurosurg 2001 ; 15:184-188.
  • 33.Taphoorn MJ,Klein M.Cognitive deficits in adult patients with brain tumours.Lancet Neurol 2004; 3:159-168.
  • 34.Yoshii Y,Tominaga D,Sugimoto K,Tsuchida Y,Hyodo A,Yonaha H,et al.Cognitive function of patients with brain tumor in pre-and postoperative stage.Surg Neurol 2008; 69:51-61.
  • 35.Klein M,Taphoom MJ,Heimans JJ,van der Ploeg HM,Vandertop WP,Smit EF,et al.Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients.J Clin Oncol 2001; 19:4037-4047.
  • 36.Talacchi A,Santini B,Savazzi S,Gerosa M.Cognitive effects of tumour and surgical treatment in glioma patients.J Neurooncol 2011; 103:541-549.
  • 37.Kao GD,Goldwein JW,Schultz DJ,Radcliffe J,Sutton L,Lange B.The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors.Cancer 1994; 74:965-971.
  • 38.Chapman CA,Waber DP,Bemstein JH,Pomeroy SL,LaVally B,Sallan SE,et al.Neurobehavioral and neurologic outcome in long-term survivors of posterior fossa brain tumors:role of age and perioperative factors.J Child Neurol 1995; 10:209-212.
  • 39.llveskoski I,Pihko H,Wiklund T,Lamminranta S,Perkkio M,Makipemaa A,et al.Neuropsychologic late effects in children with malignant brain tumors treated with surgery,radiotherapy and "8 in 1" chemotherapy.Neuropediatrics 1996; 27:124-129.
  • 40.Gazzeri R,Galarza M,Gazzeri G Giant olfactory groove meningioma:ophthalmological and cognitive outcome after bifrontal microsurgical approach.Acta Neurochir (Wien)2008; 150:1117-1126.
  • 41.Mulhern RK,Kun LE.Neuropsychologic function in children with brain tumors:Ⅲ.Interval changes in the six months following treatment.Med Pediatr Oncol 1985; 13:318-324.
  • 42.Duffau H,Capelle L,Denvil D,Sichez N,Gatignol P,Lopes M,et al.Functional recovery after surgical resection of low grade gliornas in eloquent brain:hypothesis of brain compensation.J Neurol Neurosurg Psychiatry 2003; 74:901-907.
  • 43.Duffau H,Capelle L,Denvil D,Sichez N,Gatignol P,Taillandier L,et al.Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions:functional results in a consecutive series of 103 patients.J Neurosurg 2003; 98:764-778.
  • 44.Braun V,Albrecht A,Kretschmer T,Richter HP,Wunderlich A.Brain tumour surgery in the vicinity of short-term memory representation-results of neuronavigation using fMRI images.Acta Neurochir (Wien) 2006; 148:733-739.
  • 45.Giovagnoli AR,Casazza M,Ciceri E,Avanzini G,Broggi G.Preserved memory in temporal lobe epilepsy patients after surgery for low-grade tumour.A pilot study.Neurol Sci 2007;28:251-258.
  • 46.Teixidor P,Gatignol P,Leroy M,Masuet-Aumatell C,Capelle L,Duffau H.Assessment of verbal working memory before and after surgery for low-grade glioma.J Neurooncol 2007;81:305-313.
  • 47.Correa DD,DeAngelis LM,Shi W,Thaler HT,Lin M,Abrey LE.Cognitive functions in low-grade gliomas:disease and treatment effects.J Neurooncol 2007; 81:175-184.
  • 48.Beebe DW,Ris MD,Armstrong FD,Fontanesi J,Mulhern R,Holmes E,et al.Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas:Evidence of diminished cognitive and adaptive functioning in national collaborative research studies (CCG 9891/POG 9130).J Clin Onco12005; 23:5198-5204.
  • 49.Ronning C,Sundet K,Due-Tonnessen B,Lundar T,Helseth E.Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.Pediatr Neurosurg 2005; 41:15-21.
  • 50.Steinlin M,Imfeld S,Zulauf P,Boltshauser E,Lovblad KO,Ridolfi Luthy A,et al.Neuropsychological long-term sequelae after posterior fossa tumour resection during childhood.Brain 2003; 126:1998-2008.
  • 51.Talacchi A,d'Avella D,Denaro L,Santini B,Meneghelli P,Savazzi S,et al.Cognitive outcome as part and parcel of clinical outcome in brain tumor surgery.J Neurooncol 2012;108:327-332.
  • 52.Sheline GE,Wara WM,Smith V.Therapeutic irradiation and brain injury.lnt J Radiat Oncol Biol Phys 1980; 6:1215-1228.
  • 53.DeAngelis LM,Delattre JY,Posner JB.Radiation-induced dementia in patients cured of brain metastases.Neurology 1989; 39:789-796.
  • 54.Murros KE,Toole JF.The effect of radiation on carotid arteries.A review article.Arch Neurol 1989; 46:449-455.
  • 55.Monje ML,Palmer T.Radiation injury and neurogenesis.Curr Opin Neurol 2003; 16:129-134.
  • 56.Arlt W,Hove U,Muller B,Reincke M,Berweiler U,Schwab F,et al.Frequent and frequently overlooked:treatment-induced endocrine dysfunction in adult long-term survivors of primary brain tumors.Neurology 1997; 49:498-506.
  • 57.Shors TJ,Miesegaes G,Beylin A,Zhao M,Rydel T,Gould E.Neurogenesis in the adult is involved in the formation of trace memories.Nature 2001; 410:372-376.
  • 58.Surma-aho O,Niemela M,Vilkki J,Koturi M,Brander A,Salonen O,et al.Adverse long-term effects of brain radiotherapy in adult low-grade gliorna patients.Neurology 2001; 56:1285-1290.
  • 59.Kiebert GM,Curran D,Aaronson NK,Bolla M,Menten J,Rutten EH,et al.Quality of life after radiation therapy of cerebral low-grade gliomas of the adult:results of a randomised phase Ⅲ trial on dose response (EORTC trial 22844).EORTC Radiotherapy Co-operative Group.Eur J Cancer 1998; 34:1902-1909.
  • 60.Douw L,Klein M,Fagel SS,van den Heuvel J,Taphoorn MJ,Aaronson NK,et al.Cognitive and radiological effects of radiotherapy in patients with low-grade glioma:long-term follow-up.Lancet Neurol 2009; 8:810-818.
  • 61.Corn BW,Yousem DM,Scott CB,Rotman M,Asbell SO,Nelson DF,et al.White matter changes are correlated significantly with radiation dose.Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).Cancer 1994;74:2828-2835.
  • 62.Armstrong CL,Hunter JV,Ledakis GE,Cohen B,Tallent EM,Goldstein BH,et al.Late cognitive and radiographic changes related to radiotherapy:initial prospective findings.Neurology 2002; 59:40-48.
  • 63.Imperato JP,Paleologos NA,Vick NA.Effects of treatment on long-term survivors with malignant astrocytomas.Ann Neurol 1990; 28:818-822.
  • 64.Correa DD,Shi W,Thaler HT,Cheung AM,DeAngelis LM,Abrey LE.Longitudinal cognitive follow-up in low grade gliomas.J Neuroonco12008; 86:321-327.
  • 65.Laack NN,Brown PD,Ivnik RJ,Furth AF,Ballman KV,Hammack JE,et al.Cognitive function after radiotherapy for supratentorial low-grade glioma:a North Central Cancer Treatment Group prospective study.Int J Radiat Oncol Biol Phys 2005; 63:1175-1183.
  • 66.Jalali R,Mallick I,Dutta D,Goswami S,Gupta T,Munshi A,et al.Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.Int J Radiat Oncol Biol Phys 2010; 77:974-979.
  • 67.Aoyama H,Shirato H,Tago M,Nakagawa K,Toyoda T,Hatano K,et al.Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases:a randomized controlled trial.JAMA 2006; 295:2483-2491.
  • 68.Aoyama H,Tago M,Kato N,Toyoda T,Kenjyo M,Hirota S,et al.Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotaetie radiosurgery or radiosurgery alone.lnt J Radiat Oncol Biol Phys 2007; 68:1388-1395.
  • 69.Chang EL,Wefel JS,Hess KR,Allen PK,Lang FF,Komguth DG,et al.Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation:a randomised controlled trial.Lancet Oncol 2009;10:1037-1044.
  • 70.Roos DE,Wirth A,Burmeister BH,Spry NA,Drummond KJ,Beresford JA,et al.Whole brain irradiation following surgery or radiosurgery for solitary brain metastases:mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05).Radiother Oncol 2006;80:318-322.
  • 71.Correa DD,DeAngelis LM,Shi W,Thaler H,Glass A,Abrey LE.Cognitive functions in survivors of primary central nervous system lymphoma.Neurology 2004; 62:548-555.
  • 72.Klein M,Engelberts NH,van der Ploeg HM,Kasteleijn-Nolst Trenite DG,Aaronson NK,Taphoorn MJ,et al.Epilepsy in low-grade gliomas:the impact on cognitive function and quality of life.Ann Neurol 2003; 54:514-520.
  • 73.Aldenkamp AP.Effects of antiepileptic drugs on cognition.Epilepsia 2001; 42 Suppl 1:46-51.
  • 74.Taphoom MJ.Neurocognitive sequelae in the treatment of low-grade gliomas.Semin Oncol 2003; 30 (6 Suppl 19):45-48.
  • 75.Maschio M,Dinapoli L,Sperati F,Pace A,Fabi A,Vidiri A,et al.Levetiracetam monotherapy in patients with brain tumor-related epilepsy:seizure control,safety,and quality of life.J Neurooncol 2011 ; 104:205-214.
  • 76.Meador KJ.Cognitive outcomes and predictive factors in epilepsy.Neurology 2002; 58 (8 Suppl 5):S21-S26.
  • 77.Maschio M,Dinapoli L.Lecture:profile of risks and benefits of new antiepileptic drugs in brain tumor-related epilepsy.Neurol Sci 2011; 32 Suppl 2:S259-S262.
  • 78.Drane DL,Meador KJ.Cognitive and behavioral effects of antiepileptic drugs.Epilepsy Behav 2002; 3 (5S):49-53.
  • 79.Tatum WO,French JA.Lamotrigine and side effects:Another headache.Neurology 2012; 78:849-850.
  • 80.Loring DW,Williamson DJ,Meador KJ,Wiegand F,Hulihan J.Topiramate dose effects on cognition:a randomized double-blind study.Neurology 2011; 76:131-137.
  • 81.Milovan D,Almeida L,Romach MK,Nunes T,Rocha JF,Sokowloska M,et al.Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers.Epilepsy Behav 2010; 18:366-373.
  • 82.Keime-Guibert F,Napolitano M,Delattre JY.Neurological complications of radiotherapy and chemotherapy.J Neurol 1998; 245:695-708.
  • 83.Raffa RB,Tallarida RJ.Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy-induced "chemo-fog".J Clin Pharm Ther 2010; 35:249-255.
  • 84.Wen PY.Central nervous system complications of cancer therapy.In:Schiff D,Wen PY,eds.Cancer neurology in clinical practice.Totowa:Humana Press; 2003:215-231.
  • 85.Shapiro WR,Green SB.Reevaluating the efficacy of intra-arterial BCNU.J Neurosurg 1987; 66:313-315.
  • 86.Shapiro WR,Green SB,Burger PC,Selker RG,VanGilder JC,Robertson JT,et al.A randomized comparison of intra-arterial versus intravenous BCNU,with or without intravenous 5-fluorouracil,for newly diagnosed patients with malignant glioma.J Neurosurg 1992; 76:772-781.
  • 87.Correa D,Anderson ND,Glass A,Mason WP,DeAngelis LM,Abrey LE.Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation:preliminary findings.Clin Adv Hematol Oncol 2003; 1:490.
  • 88.Fliessbach K,Urbach H,Helmstaedter C,Pels H,Glasmacher A,Kraus JA,et al.Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.Arch Neurol 2003; 60:563-568.
  • 89.Fliessbach K,Helmstaedter C,Urbach H,Althaus A,Pels H,Linnebank M,et al.Neuropsychological outcome after chemotherapy for primary CNS lymphoma:a prospective study.Neurology 2005; 64:1184-1188.
  • 90.Herrlinger U,Kuker W,Uhl M,Blaicher HP.Karnath HO,Kanz L,et al.NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma:final report.Ann Neurol 2005; 57:843-847.
  • 91.Hwang TL,Yung WK,Estey EH,Fields WS.Central nervous system toxicity with high-dose Ara-C.Neurology 1985; 35:1475-1479.
  • 92.Shapiro WR,Chernik NL,Posner JB.Necrotizing encephalopathy following intraventricular instillation of methotrexate.Arch Neurol 1973; 28:96-102.
  • 93.Boogerd W,vd Sande J J,Moffie D.Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate.J Neurol Neurosurg Psychiatry 1988; 51:1277-1283.
  • 94.Herzig RH,Hines JD,Herzig GP,Wolff SN,Cassileth PA,Lazarus HM,et al.Cerebellar toxicity with high-dose cytosine arabinoside.J Clin Oncol; 5:927-932.
  • 95.Saykin AJ,Ahles TA,McDonald BC.Mechanisms of chemotherapy-induced cognitive disorders:neuropsychological,pathophysiological,and neuroimaging perspectives.Semin Clin Neuropsychiatry 2003; 8:201-216.
  • 96.Postma TJ,van Groeningen CJ,Witjes RJ,Weerts JG,Kralendonk JH,Heimans JJ.Neurotoxicity of combination chemotherapy with procarbazine,CCNU and vincristine (PCV) for recurrent glioma.J Neurooncol 1998; 38:69-75.
  • 97.Hilverda K,Bosma I,Heimans JJ,Postma TJ,Peter Vandertop W,Slotman BJ,et al.Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment:initial findings.J Neurooneol 2010; 97:89-94.
  • 98.Vamey NR,Alexander B,Maclndoe JH.Reversible steroid dementia in patients without steroid psychosis.Am J Psychiatry 1984; 141:369-372.
  • 99.Domes G,Heinrichs M,Reichwald U,Hautzinger M.Hypothalamic-pituitary-adrenal axis reactivity to psychological stress and memory in middle-aged women:high responders exhibit enhanced declarative memory performance.Psychoneuroendocrinology 2002; 27:843-853.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn